What does a urine sodium of 31 mEq/L, urine chloride of 22 mEq/L, urine creatinine of 292 mg/dL, serum creatinine of 10.6 mg/dL, and urine osmolality of 167 mOsm/kg indicate about the type of acute kidney injury?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of Urine Studies in Acute Kidney Injury

Primary Assessment: These Values Indicate Intrinsic Renal Injury (Acute Tubular Necrosis)

The combination of urine sodium 31 mEq/L, urine chloride 22 mEq/L, urine creatinine 292 mg/dL, serum creatinine 10.6 mg/dL, and urine osmolality 167 mOsm/kg strongly suggests acute tubular necrosis (ATN) rather than prerenal azotemia. 1

Detailed Interpretation of Each Parameter

Urine Sodium (31 mEq/L)

  • A urine sodium >40 mEq/L is the traditional threshold for ATN, but values between 20-40 mEq/L fall into an intermediate zone that, when combined with other indices, typically indicates intrinsic renal injury rather than prerenal causes. 1
  • In prerenal azotemia, the kidneys avidly retain sodium and urine sodium is typically <20 mEq/L; your value of 31 mEq/L suggests the tubules have lost their ability to concentrate sodium appropriately. 1

Urine Chloride (22 mEq/L)

  • Urine chloride parallels sodium handling in most AKI scenarios; a value of 22 mEq/L is borderline but leans toward tubular dysfunction when interpreted alongside the other indices. 1

Urine Osmolality (167 mOsm/kg)

  • This is the most definitive finding: a urine osmolality <350 mOsm/kg strongly indicates ATN, as the damaged tubules cannot concentrate urine. 1
  • In prerenal azotemia, urine osmolality is typically >500 mOsm/kg because intact tubules maximally concentrate urine in response to hypoperfusion. 1
  • Your value of 167 mOsm/kg is essentially isotonic with plasma (~290 mOsm/kg), confirming severe tubular concentrating defect. 1

Calculated Indices from Available Data

Urine-to-Plasma Creatinine Ratio

  • With urine creatinine 292 mg/dL and serum creatinine 10.6 mg/dL, the ratio is approximately 27.5. 1
  • A ratio <20 suggests ATN; values >40 indicate prerenal azotemia. Your ratio of 27.5 falls in the intermediate range but closer to the ATN threshold, especially when combined with the low urine osmolality. 1

Fractional Excretion of Sodium (FENa)

  • Although you did not provide serum sodium, the FENa formula is: (Urine Na × Serum Cr) / (Serum Na × Urine Cr) × 100. 1
  • FENa >2% indicates ATN; FENa <1% suggests prerenal azotemia. 1
  • Given your urine sodium of 31 mEq/L and the context of dilute urine, the FENa is likely >1%, supporting intrinsic renal injury. 1

Renal Failure Index (RFI)

  • RFI = Urine Na / (Urine Cr / Serum Cr). 1
  • Using your values: 31 / (292/10.6) = 31 / 27.5 ≈ 1.13. 1
  • An RFI >2 definitively indicates ATN; an RFI <1 suggests prerenal azotemia. Your RFI of 1.13 is borderline but, combined with the profoundly low urine osmolality, supports ATN over prerenal causes. 1

Clinical Context and KDIGO Staging

Severity of AKI

  • A serum creatinine of 10.6 mg/dL meets KDIGO Stage 3 AKI criteria (≥4.0 mg/dL with an acute rise ≥0.3 mg/dL, or ≥3× baseline). 2, 3, 4
  • Stage 3 AKI mandates immediate nephrology consultation and consideration for renal replacement therapy if complications arise. 3, 4

Urine Creatinine as a Dynamic Marker

  • Urine creatinine concentration reflects both GFR and urine flow; in oliguric ATN, urine creatinine may be elevated (as in your case, 292 mg/dL) because the small volume of urine produced is relatively concentrated for creatinine even though osmolality is low. 5
  • Changes in urine indices precede changes in serum creatinine by at least one day, making urine studies valuable for early detection of worsening or recovery. 6, 5

Immediate Management Priorities

Discontinue Nephrotoxins

  • Stop all NSAIDs, ACE inhibitors, ARBs, diuretics, aminoglycosides, and any other nephrotoxic agents immediately. 3, 4, 7

Nephrology Consultation

  • KDIGO mandates urgent nephrology referral for Stage 3 AKI (serum creatinine ≥4.0 mg/dL or ≥3× baseline). 3, 4

Assess for Dialysis Indications

  • Emergent renal replacement therapy is indicated for refractory hyperkalemia, severe metabolic acidosis (pH <7.1), or volume overload causing pulmonary edema. 3, 4, 7

Fluid Management

  • In ATN, fluid resuscitation does not reverse the injury but euvolemia should be maintained; avoid both hypovolemia and volume overload. 7

Serial Monitoring

  • Measure serum creatinine and electrolytes every 4–6 hours initially to track trajectory and detect life-threatening complications. 3, 4

Common Pitfalls to Avoid

  • Do not rely on a single urinary index in isolation; the combination of low urine osmolality (<350 mOsm/kg), elevated urine sodium (>20 mEq/L), and borderline urine-to-plasma creatinine ratio collectively confirm ATN. 1
  • Do not use standard eGFR equations (MDRD, CKD-EPI) when serum creatinine is changing rapidly; they are validated only for stable chronic kidney disease. 3, 4
  • Do not delay nephrology consultation or dialysis when Stage 3 AKI is present; mortality increases significantly with delayed intervention. 3, 4

Follow-Up Strategy

  • Arrange nephrology follow-up within 1–2 weeks for Stage 3 AKI to assess recovery and plan long-term management. 3, 4
  • Re-evaluate kidney function at 90 days post-AKI to determine progression to chronic kidney disease, as the 7–90 day window defines acute kidney disease (AKD). 2, 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Guideline Recommendations for Management of Worsening Acute Kidney Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Acute Kidney Injury

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Acute kidney injury: a guide to diagnosis and management.

American family physician, 2012

Related Questions

What outpatient labs are recommended for a patient with a recent Acute Kidney Injury (AKI)?
What is the next step in managing a patient with acute kidney injury, hyponatremia, anemia, and oliguria?
What is the most likely cause of acute kidney injury in a 76‑year‑old woman with hypertension and diabetes on valsartan who had severe vomiting and diarrhea, resulting in a creatinine rise from 0.6 to 1.6 mg/dL, low BUN/creatinine ratio, urine sodium 60 mEq/L, low specific gravity, and urine osmolality 220 mOsm/kg?
What is the most likely cause of kidney injury in an elderly patient with a history of hypertension and diabetes, presenting with signs of dehydration, severe vomiting, and diarrhea, and lab results showing elevated creatinine (Impaired renal function), low urine osmolality, and specific gravity, after a recent primary physician appointment?
Which of the following statements about pre‑renal and post‑renal acute kidney injury are correct? a. Urinary sodium concentration in pre‑renal acute kidney injury is above 40 mmol/L; b. Erythrocyte casts are present in the urine sediment of post‑renal acute kidney injury; c. The urea‑to‑creatinine ratio exceeds 50 in pre‑renal acute kidney injury; d. Urine osmolality is higher in post‑renal than in pre‑renal acute kidney injury; e. Urine sediment may be bland (without casts or cells) in pre‑renal acute kidney injury.
In adults with atherosclerotic cardiovascular disease or diabetes with risk factors who are on maximally tolerated statin therapy, what is icosapent ethyl (Vascepa) used for?
In a 16‑week pregnant woman with an elevated D‑dimer, which imaging study should be ordered first to evaluate for venous thrombo‑embolism?
What is the optimal treatment strategy for metastatic bladder cancer, including first‑line cisplatin‑eligible versus cisplatin‑ineligible regimens, maintenance avelumab, second‑line checkpoint inhibitors, FGFR‑targeted therapy, and enfortumab vedotin?
Is a prostate-specific antigen level of 8.3 ng/mL concerning in a 67‑year‑old man recovering from stage III mediastinal‑node non‑small cell lung carcinoma after lobectomy?
What is a mecA (methicillin resistance gene A) or mecC (methicillin resistance gene C) resistance marker?
What is the next step in managing a patient with knee pain and a normal knee radiograph?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.